New Study Reveals Promising Outcomes for Minimally Invasive Sacrospinous Ligament Fixation Using EnPlace® for Treating Pelvic Organ Prolapse in Older Women
17 oct. 2024 10h00 HE | FEMSelect Ltd.
NEWARK, Del., Oct. 17, 2024 (GLOBE NEWSWIRE) -- A new study published last week in the “Journal of Clinical Medicine” has revealed promising results for sacrospinous ligament (SSL) fixation using...
Screenshot 2024-08-16 at 10.43.20 AM.png
Doctor's Best Introduces New Line of Supplements: For Women, From Women
22 août 2024 07h00 HE | Doctor's Best
A new science-backed collection formulated to keep your health in check at every important life stage.
LevLane Advertising and Rosy Wellness Release Women's Health White Paper: "The Women Are Not Alright"
LevLane Advertising and Rosy Wellness Release Women's Health White Paper: "The Women Are Not Alright"
20 juin 2024 10h00 HE | LevLane
PHILADELPHIA, June 20, 2024 (GLOBE NEWSWIRE) -- LevLane Advertising, one of Philadelphia's oldest independent, full-service advertising agencies, and Rosy Wellness, the Webby Award-winning...
LevLane Advertising, one of Philadelphia's oldest independent full-service advertising agencies, was awarded an Anvil Award.
LevLane Advertising Wins PRSA Anvil Award for Best Feature Article Addressing Bias Against Use of Biological Terms in Women's Health Marketing and Advertising
28 mai 2024 08h00 HE | LevLane
PHILADELPHIA, May 28, 2024 (GLOBE NEWSWIRE) -- LevLane Advertising, one of Philadelphia's oldest independent full-service advertising agencies, was awarded an Anvil Award for the prestigious...
Frontier Nursing Uni
Frontier Nursing University and Campion Fund to Host Maternal Mortality Conference
22 mai 2024 08h09 HE | Frontier Nursing University
Versailles, Ky, May 22, 2024 (GLOBE NEWSWIRE) -- Frontier Nursing University (FNU) and the Campion Fund announced plans for a conference focused on the nation’s maternal mortality crisis. “Reducing...
Amplexd Logo Text 250.png
Amplexd Therapeutics, Innovating to Revolutionize the Future of Non-Invasive HPV-induced Cervical Intraepithelial Neoplasia (CIN) Treatments for the Prevention of Cervical Cancer: Developed by Women for Women
21 mai 2024 08h00 HE | Amplexd Therapeutics Inc.
GAITHERSBURG, MD, May 21, 2024 (GLOBE NEWSWIRE) -- Amplexd Therapeutics, Inc. (“Amplexd” or the “Company”), a clinical stage patient-scientist-led biotech company specializing in accessible...
Amplexd Logo Text 250.png
Amplexd Therapeutics, Innovating to Revolutionize the Future of Non-Invasive HPV-induced Cervical Intraepithelial Neoplasia (CIN) Treatments for the Prevention of Cervical Cancer: Developed by Women for Women
19 mai 2024 20h00 HE | Amplexd Therapeutics Inc.
GAITHERSBURG, MD, May 20, 2024 (GLOBE NEWSWIRE) -- Amplexd Therapeutics, Inc. (“Amplexd” or the “Company”), a clinical stage patient-scientist-led biotech company specializing in accessible...
Agile_Logo-color on white.jpg
Agile Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update
15 mai 2024 16h10 HE | Agile Therapeutics, Inc.
First Quarter Net Revenue Increased 58% and Factory Sales Increased 3% from Fourth Quarter 2023 Twirla First Quarter 2024 Demand Rebounded 18% from Fourth Quarter 2023 PRINCETON, N.J., May 15,...
3daughters.jpg
3Daughters Announces Three New Appointments to Board of Directors
13 mars 2024 08h00 HE | 3Daughters
MANSFIELD, Mass., March 13, 2024 (GLOBE NEWSWIRE) -- 3Daughters, a clinical development company fueling evolutionary healthcare for women, announced the appointment of Michele LaRussa, Vincent J....
BIO.png
BioAdaptives, Inc. Commences Development of a New Supplement for Women’s Health
05 oct. 2023 08h00 HE | BioAdaptives, Inc.
PluriPain®-PMS is an Advanced Derivative of the Company’s Popular Supplement, PluriPain® LAS VEGAS, NV, Oct. 05, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – BioAdaptives, Inc. (OTC: BDPT), a...